Arzeda Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Arzeda Corp (Arzeda) is a biotechnology company that develops biological solutions for transformative products. The companys products include novel crop traits, 1, 3-butadiene, levulinic acid, and methane. Its services comprise enzyme design, metabolic engineering, and protein optimization services. Arzeda utilizes natural environments for bulk synthesis that carries manufacture of important universal industrial building blocks such as butanol, isoprene or adipic acid; and potential to create building block precursors with different properties. The company designs cell factories for producing specialty and bulk chemicals. Its products are used for improvement of both crop yields and farming resource efficiency. The company partners with agriculture and biotech partners to develop novel products. Arzeda is headquartered in Seattle, Washington, the US.

Arzeda Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Arzeda Corp, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Arzeda Raises Additional USD3.2 Million in Series A Financing 9
Arzeda Raises USD12 Million in Series A Financing 10
Partnerships 11
Zymergen Enters into Co-Development Agreement with Arzeda 11
Arzeda Corp - Key Competitors 12
Arzeda Corp - Key Employees 13
Arzeda Corp - Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Corporate Communications 15
Dec 21, 2017: Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


Arzeda Corp, Pharmaceuticals & Healthcare, Key Facts 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Arzeda Raises Additional USD3.2 Million in Series A Financing 9
Arzeda Raises USD12 Million in Series A Financing 10
Zymergen Enters into Co-Development Agreement with Arzeda 11
Arzeda Corp, Key Competitors 12
Arzeda Corp, Key Employees 13

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Arzeda Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Arzeda Corp (Arzeda) is a biotechnology company that develops biological solutions for transformative products. The companys products include novel crop traits, 1, 3-butadiene, levulinic acid, and methane. Its services comprise

USD 250 View Report

The Depository Trust & Clearing Corp - Strategic SWOT Analysis Review

The Depository Trust & Clearing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed

USD 125 View Report

Sunflower Electric Power Corp - Strategic SWOT Analysis Review

Sunflower Electric Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available